EXPERIENCES WITH NEW ANTIRHEUMATIC DRUG IN PRACTICE

被引:0
|
作者
ZIEGELMAYER, W [1 ]
机构
[1] FACHARZT INNERE KRANKHEITEN, FRIEDRICH EBERT ANLAGE 39, 6 FRANKFURT MAIN, WEST GERMANY
来源
MEDIZINISCHE WELT | 1974年 / 25卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:426 / 428
页数:3
相关论文
共 50 条
  • [21] Antirheumatic drug toxicity in children
    不详
    HOSPITAL MEDICINE, 1999, 60 (01): : 69 - 69
  • [22] AN IMMUNOPHARMACOLOGICAL PROFILE OF LOBENZARIT DISODIUM (CCA), A NEW IMMUNOMODULATING ANTIRHEUMATIC DRUG
    OHSUGI, Y
    NAKANO, T
    UENO, K
    FUKUI, H
    NIKI, R
    SUGAWARA, Y
    HATA, S
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1985, 1 (02): : 85 - 92
  • [23] Drug-drug interactions in antirheumatic treatment
    Krueger, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (03): : 209 - 215
  • [24] EFFECTS OF BUCILLAMINE, A NEW ANTIRHEUMATIC DRUG, ON THE EXPERIMENTAL AUTOIMMUNE UVEITIS IN RATS
    SAWA, K
    MOCHIZUKI, M
    EXPERIMENTAL EYE RESEARCH, 1994, 58 (04) : 431 - 438
  • [25] MODULATION OF ACUTE PHASE PROTEINS BY TENIDAP, A NEW ANTIINFLAMMATORY, ANTIRHEUMATIC DRUG
    LOOSE, LD
    LITTMAN, BH
    SIPE, JD
    CLINICAL RESEARCH, 1990, 38 (02): : A579 - A579
  • [26] IMMUNOMODULATING EFFECTS OF THE NEW ANTIRHEUMATIC DRUG TENIDAP ON COLLAGEN-INDUCED
    MATSUSHITA, I
    MATSUNO, H
    KADOWAKI, KM
    OKADA, C
    TSUJI, H
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (03): : 213 - 219
  • [27] NAPROXEN, A SPECIFIC ANTIRHEUMATIC DRUG
    ALTMANN, H
    KLEIN, G
    WOTTAWA, A
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (NA2): : 293 - 293
  • [28] Validation of New Antirheumatic Drug Use as a Proxy for Increased JIA Disease Activity
    Gabbeta, Avinash
    Mulvihill, Evan
    Beukelman, Timothy
    Lewis, James
    Rose, Carlos
    Strom, Brian
    Horton, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [29] DRUG-DRUG INTERACTION WITH THE USE OF ANTIRHEUMATIC DRUGS
    ARNESON, HT
    COLTON, RS
    MINNESOTA MEDICINE, 1987, 70 (10) : 589 - &